Anticancer activity of lichen-derived compounds against triple-negative breast cancer: integrated in vitro evaluation, network pharmacology, molecular docking, and KEGG pathway analysis.

Sachin V. Mapari S. Gaikwad Ruchira R. Sutar Roshni Khare Ravindra M. Patil Bhaskar C. Behera

Aug 2026 · Naunyn-Schmiedeberg's Archives of Pharmacology · 0 citations · 36 references

Medicine

TL;DR

Lichen-derived compounds atranorin, barbatic acid, and usnic acid demonstrated anticancer activity in vitro, while integrated computational analyses suggested potential multitarget interactions that warrant further experimental validation.

DOI PubMed Semantic Scholar

View source

Similar papers

Open access 2026

Integrating in silico modeling and experimental validation to determine the anti-breast cancer mechanisms of mulberry leaf bioactive compounds.

The results of the present study suggest that ML can inhibit the proliferation and migration of BRCA cells whilst inducing their apoptosis by regulating the expression of key proteins.

Jun Zhang, Guo-Xin Zhao, Renping Zhang et al. · American Journal of Cancer R... · 0 citations

2026

In silico evaluation of phytocompounds targeting drug resistance mechanisms in triple-negative breast cancer: Insights from GEO dataset analysis

It is suggested that kirenol, artesunate, apigenin, daidzein, and sclareol have the potential to target specific genes involved in chemoresistance in TNBC and can serve as therapeutic options against drug-resistant TNBC.

R. Raj, S. Dang, R. Gabrani · Medicinal Plants - Internati... · 0 citations

Open access Aug 2026

Active ingredients and molecular targets of Tripterygium wilfordii against colorectal cancer: network pharmacology, molecular docking, molecular dynamics simulations and in vitro evaluation

Tryptophenolide (Lei4) showed moderate but reproducible anti-CRC activity and directly inhibited EGFR kinase activity in vitro, supporting EGFR pathway inhibition as one mechanism contributing to its cellular effects.

Qian Gu, Shi-Lei Zhao, Xin Zhang et al. · Journal of Computer-Aided Mo... · 0 citations

Open access Aug 2026

RRx-001 Accelerates Low Dose Oxaliplatin-Induced Cytotoxicity in Triple-Negative Breast Cancer Cells via Synergistic Antitumor Mechanisms

Background: Triple-negative breast cancer (TNBC) represents an aggressive subtype that has few therapeutic options for targeting and is highly resistant to chemotherapy. The compound RRx-001 is a dinitroazetidine compound with both immune-modulating and epigenetic properties, whereas oxaliplatin elicits immunogenic cel...

R. K. Al-Fatlawi, W. Al-khfajy · Al-Rafidain Journal of Medic... · 0 citations

Open access Aug 2026

In silico and in vitro evaluation of synergistic anticancer effects of erucin and kaempferol from Eruca sativa against human A549 non-small cell lung cancer cells (NSCLC)

The erucin-kaempferol combination demonstrated synergistic anticancer activity against A549 NSCLC cells, highlighting the bioactive potential of naturally co-occurring E. sativa-derived phytochemicals.

Akshay Kumar, Nakul Bhardwaj, Rahul Sharma et al. · Cytotechnology (Dordrecht) · 0 citations

Open access Jul 2026

Integrated Computational and Experimental Discovery of Antitumoral Peptides Targeting Luminal A and Triple-Negative Breast Cancer

The combined computational and experimental approach enabled the identification of peptides with selective cytotoxic effects and favorable predicted immunogenic profiles, demonstrating that integrating computational screening with experimental validation is an effective strategy for accelerating the discovery of select...

Isabella Fagundes Gurgel, Ana Carolini Almeida Marcarini, Carlos Marchiorio Lacerda et al. · International Journal of Pep... · 0 citations